Barrett's oesophagus: an ideal model to study cancer genetics

被引:12
作者
di Pietro, Massimiliano [1 ]
Fitzgerald, Rebecca C. [1 ]
机构
[1] Hutchison MRC Res Ctr, Canc Cell Unit, Cambridge CB2 0XZ, England
基金
英国医学研究理事会;
关键词
GASTROESOPHAGEAL-REFLUX DISEASE; HIGH-GRADE DYSPLASIA; NITRIC-OXIDE SYNTHASE; DNA-REPAIR GENES; FACTOR-KAPPA-B; BILE-ACIDS; MOLECULAR PATHOGENESIS; NEOPLASTIC PROGRESSION; INTESTINAL METAPLASIA; SQUAMOUS EPITHELIUM;
D O I
10.1007/s00439-009-0665-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chronic gastro-oesophageal reflux disease can induce a metaplastic change of the distal oesophagus called Barrett's oesophagus whereby the normal squamous epithelium is substituted by a columnar epithelium. Patients with Barrett's oesophagus are at increased risk of oesophageal adenocarcinoma which occurs through dysplastic stages with increasing degree of cellular and architectural disorganization. Barrett's oesophagus represents an ideal model to study the genetic events supporting the onset of an invasive tumour since patients with this condition are surveilled with endoscopic tissue sampling until high grade dysplasia or intramucosal carcinoma develop. However, due to the relatively low incidence of this disease compared to other cancers, i.e. colon and breast, it is only recently that researchers have concentrated on understanding the genetic events supporting the onset of Barrett's and its transformation to cancer. Here, we review the knowledge acquired so far on the genetic and molecular alterations along the oesophageal metaplasia-dysplasia-carcinoma sequence.
引用
收藏
页码:233 / 246
页数:14
相关论文
共 183 条
[1]   Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenes [J].
Abdalla, SI ;
Lao-Sirieix, P ;
Novelli, MR ;
Lovat, LB ;
Sanderson, IR ;
Fitzgerald, RC .
CLINICAL CANCER RESEARCH, 2004, 10 (14) :4784-4792
[2]   Met receptor signaling: A key effector in esophageal adenocarcinoma [J].
Anderson, Mark R. ;
Harrison, Rebecca ;
Atherfold, Paul A. ;
Campbell, Moray J. ;
Darnton, S. Jane ;
Obszynska, Jolanta ;
Jankowski, Janusz A. Z. .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :5936-5943
[3]  
Arber N, 1996, CANCER EPIDEM BIOMAR, V5, P457
[4]   Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma [J].
Auvinen, MI ;
Sihvo, EIT ;
Ruohtula, T ;
Salminen, JT ;
Koivistoinen, A ;
Siivola, P ;
Rönnholm, R ;
Rämö, JO ;
Bergman, M ;
Salo, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) :2971-2979
[5]  
Bailey T, 1998, AM J PATHOL, V152, P135
[6]   Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma [J].
Bani-Hani, K ;
Martin, IG ;
Hardie, LJ ;
Mapstone, N ;
Briggs, JA ;
Forman, D ;
Wild, CP .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1316-1321
[7]   Endoscopic therapy for Barrett's oesophagus [J].
Barr, H ;
Stone, N ;
Rembacken, B .
GUT, 2005, 54 (06) :875-884
[8]   Evolution of neoplastic cell lineages in Barrett oesophagus [J].
Barrett, MT ;
Sanchez, CA ;
Prevo, LJ ;
Wong, DJ ;
Galipeau, PC ;
Paulson, TG ;
Rabinovitch, PS ;
Reid, BJ .
NATURE GENETICS, 1999, 22 (01) :106-109
[9]   The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma [J].
Baumann, S. ;
Keller, G. ;
Puehringer, F. ;
Napieralski, R. ;
Feith, M. ;
Langer, R. ;
Hoefler, H. ;
Stein, H. J. ;
Sarbia, M. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (02) :264-268
[10]   The role of Cdx genes in the mammalian gut [J].
Beck, F .
GUT, 2004, 53 (10) :1394-1396